Stokes Capital Advisors, LLC

Position in ABBV — AbbVie Inc.

CIK 1734460 GREENWOOD, SC

Position in ABBV

as of Jun 30, 2026 · filed Jul 22, 2026 Compact

Position Value

$9,425,427

+$1,413,531 QoQ

Shares Held

37,456

+1.7% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

2.31%

of 13F equity value

Holder Rank

#951

of 4,153 holders

Holding Since

Dec 2022

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Stokes Capital Advisors, LLC holds $39,481,428 across 8 Drug Manufacturers - General names. ABBV ranks #3 (23.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	9,779	$11,729,226
2	JNJ	Johnson & Johnson	43,686	$11,094,933
3	ABBV	AbbVie Inc. This page	37,456	$9,425,427
4	GILD	Gilead Sciences, Inc.	35,370	$4,468,645
5	AMGN	Amgen Inc	3,061	$1,108,449
6	MRK	Merck & Co., Inc.	5,373	$690,430
7	PFE	Pfizer Inc	22,925	$552,034
8	NVO	Novo Nordisk A S	8,600	$412,284

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$9,425,427	37,456	+1.7%	Shares	Sole	2026-07-22
2026-03-31	$8,011,896	36,838	+0.9%	Shares	Defined	2026-04-24
2025-12-31	$8,345,140	36,523	-3.3%	Shares	Sole	2026-01-12
2025-09-30	$8,747,349	37,779	-0.9%	Shares	Sole	2025-10-09
2025-06-30	$7,075,648	38,119	+3.7%	Shares	Sole	2025-07-09
2025-03-31	$7,704,050	36,770	+0.2%	Shares	Sole	2025-04-11
2024-12-31	$6,521,767	36,701	+4.5%	Shares	Sole	2025-01-16
2024-09-30	$6,932,930	35,107	+0.0%	Shares	Sole	2024-10-07
2024-06-30	$6,020,523	35,101	+27.9%	Shares	Sole	2024-07-19
2024-03-31	$4,998,462	27,449	+1.2%	Shares	Sole	2024-04-16
2023-12-31	$4,203,561	27,125	+1851.4%	Shares	Sole	2024-01-16
2023-09-30	$207,193	1,390	0.0%	Shares	Sole	2023-10-11
2023-03-31	$221,524	1,390	0.0%	Shares	Sole	2023-04-12
2022-12-31	$224,637	1,390	—	Shares	Sole	2023-01-18
No filing history on record for this holder in this stock.